Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009-2012

International Journal of Antimicrobial Agents

Volumn 43, Issue 4, 2014, Pages 328-334

  Sader, Helio S ^a   Farrell, David J ^a   Flamm, Robert K ^a   Jones, Ronald N ^a  

^a JMI LABORATORIES   (United States)

Author keywords

Antimicrobial resistance; ESBL; Extended spectrum lactamases; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENTEROBACTER; EUROPE; GRAM NEGATIVE BACTERIUM; KLEBSIELLA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOUTHERN EUROPE; STENOTROPHOMONAS MALTOPHILIA; UNITED STATES; DRUG EFFECTS; EPIDEMIOLOGY; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMONIA; UNITED STATES;

EID: 84897997775     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.01.007     Document Type: Article

References (26)

1. A. Arnold, S.D. Brouse, W.D. Pitcher, and R.G. Hall 2nd Empiric therapy for Gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind J Intensive Care Med 25 2010 259 270
2. H.W. Boucher, G.H. Talbot, D.K. Benjamin Jr., J. Bradley, R.J. Guidos, and R.N. Jones et al. 10 × '20 progress - development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America Clin Infect Dis 56 2013 1685 1694
3. A. Sorbello, S. Komo, T. Valappil, and S. Nambiar Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia Clin Infect Dis 51 Suppl 1 2010 S36 S41
4. M. Iregui, S. Ward, G. Sherman, V.J. Fraser, and M.H. Kollef Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia Chest 122 2002 262 268
5. S.T. Micek, A.E. Lloyd, D.J. Ritchie, R.M. Reichley, V.J. Fraser, and M.H. Kollef Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment Antimicrob Agents Chemother 49 2005 1306 1311
6. C.M. Luna, P. Vujacich, M.S. Niederman, C. Vay, C. Gherardi, and J. Matera et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia Chest 111 1997 676 685
7. American Thoracic Society, and Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 15 2005 388 416
8. A. Torres, M. Ferrer, and J.R. Badia Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia Clin Infect Dis 51 Suppl 1 2010 S48 S53
9. A. Torres, S. Ewig, H. Lode, J. Carlet, and European HAP Working Group Defining, treating and preventing hospital acquired pneumonia: European perspective Intensive Care Med 35 2009 9 29
10. R.M. Kaiser, M. Castanheira, R.N. Jones, F. Tenover, and R. Lynfield Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program Diagn Microbiol Infect Dis 76 2013 356 360
11. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M07-A9 9th ed. 2012 CLSI Wayne, PA
12. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. Document M100-S23 2013 CLSI Wayne, PA
13. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0; January 2013. http://www.eucast.org/clinical-breakpoints/ [accessed 02.01.13].
14. ® package insert 2012. http://www.tygacil.com [accessed 31.01.13].
15. C. Tanaseanu, C. Bergallo, O. Teglia, A. Jasovich, M.E. Oliva, and G. Dukart et al. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia Diagn Microbiol Infect Dis 61 2008 329 338
16. R.N. Jones Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia Clin Infect Dis 51 Suppl 1 2010 S81 S87
17. D.M. Sievert, P. Ricks, J.R. Edwards, A. Schneider, J. Patel, and A. Srinivasan et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010 Infect Control Hosp Epidemiol 34 2013 1 14
18. R.G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, and E. Brown et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy J Antimicrob Chemother 62 2008 5 34
19. J.S. Brooke Stenotrophomonas maltophilia: an emerging global opportunistic pathogen Clin Microbiol Rev 25 2012 2 41
20. Y. Cai, D. Chai, R. Wang, B. Liang, and N. Bai Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies J Antimicrob Chemother 67 2012 1607 1615
21. A.C. Gales, R.N. Jones, and H.S. Sader Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09) J Antimicrob Chemother 66 2011 2070 2074
22. H.S. Sader, D.J. Farrell, and R.N. Jones Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006-2009) Int J Antimicrob Agents 37 2011 174 175
23. A.C. Gales, H.S. Sader, and T.R. Fritsche Tigecycline activity tested against 11,808 bacterial pathogens recently collected from US medical centers Diagn Microbiol Infect Dis 60 2008 421 427
24. L.R. Peterson A review of tigecycline - the first glycylcycline Int J Antimicrob Agents 32 Suppl 4 2008 S215 S222
25. M. Castanheira, S.E. Farrell, A. Wanger, K.V. Rolston, R.N. Jones, and R.E. Mendes Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages Microb Drug Resist 19 2013 295 297
26. M. Castanheira, S.E. Farrell, L.M. Deshpande, R.E. Mendes, and R.N. Jones Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 USA hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010) Antimicrob Agents Chemother 57 2013 3012 3020